Order Article Reprints

Sidorova OA, Sayed S, Paszkowski-Rogacz M, Seifert M, Camgöz A, Roeder I, Bornhäuser M, Thiede C, Buchholz F. RNAi-Mediated Screen of Primary AML Cells Nominates MDM4 as a Therapeutic Target in NK-AML with DNMT3A Mutations. Cells. 2022; 11(5):854. https://doi.org/10.3390/cells11050854

Sidorova, Olga Alexandra, Shady Sayed, Maciej Paszkowski-Rogacz, Michael Seifert, Aylin Camgöz, Ingo Roeder, Martin Bornhäuser, Christian Thiede, and Frank Buchholz. 2022. "RNAi-Mediated Screen of Primary AML Cells Nominates MDM4 as a Therapeutic Target in NK-AML with DNMT3A Mutations" Cells 11, no. 5: 854. https://doi.org/10.3390/cells11050854

Sidorova, O. A., Sayed, S., Paszkowski-Rogacz, M., Seifert, M., Camgöz, A., Roeder, I., Bornhäuser, M., Thiede, C., & Buchholz, F. (2022). RNAi-Mediated Screen of Primary AML Cells Nominates MDM4 as a Therapeutic Target in NK-AML with DNMT3A Mutations. Cells, 11(5), 854. https://doi.org/10.3390/cells11050854